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A series of gold(I) pioneer complexes bearing N-heterocyclic
carbenes and steroid derivatives (ethynylestradiol and ethister-
one) with the generic formula [Au(R2-imidazol-2-ylidene)(ste-
roid)] (where R=CH3 or CH2CH2OCH3) were synthesized, and
the X-ray structure of a rare of gold(I)–estradiol derivative is
discussed. Toxicity studies reveal notable antibacterial activity
of the gold-based compounds, which is significantly increased
in vivo by the presence of the estradiol unit. Toxicity profiling
was estimated in vitro versus Gram-positive (Staphylococcus
aureus) and Gram-negative (Escherichia coli) bacteria, and
in vivo on Galleria mellonella larvae against E. coli.
The search and design of novel compounds exhibiting antibac-
terial or antimicrobial activity has evolved in line with the
progress of chemistry, and today there is a wide variety of ex-
amples. An interesting case is that of metal complexes, already
used in ancient times, which confer attributes not found in
natural products or derivatives. Modern variations of such
complexes are closely related to cutting-edge ligands in
chemistry, as those based on N-heterocyclic carbenes (NHCs).[1]
In fact, they have grown in importance as ligands in bioactive
complexes over the last few years. The first report on antibac-
terial and antifungal properties of metal–NHC complexes dates
from 1996,[2] and since then, their use has become wide-
spread.[3] In particular, the incorporation of NHC ligands to the
bioactive silver and gold metals has opened up new possibili-
ties for the design of novel compounds. Thus, while Ag–NHC
complexes exhibit excellent properties as antimicrobials,[4] anti-
bacterials,[5] antibiotics,[6] or anticancer agents,[7] the antitumor
activity of certain gold complexes, underpinned in many cases
by the stability of their AuI–NHC bonds,[8] has been the focus
of numerous investigations.[7,9] Nevertheless, although less
common, there are a number of NHC-based gold compounds
that show antimicrobial activity.[10]
In this work, we further develop the nature of antimicrobial
AuI–NHC complexes. Our approach is an attempt to improve
the activity of these compounds by molecular camouflage,
with the incorporation of an estrogen derivative to the coordi-
nation sphere of the AuI center. Estrogens have been used in
the past as targeting ligands to synthesize selective metal-
based anticancer drugs.[11] Steroids such as estradiol and tes-
tosterone are an important class of carrier molecules for anti-
cancer agents; sex hormones play an important role in the
growth and development of certain types of cancer cells (e.g. ,
ovarian and prostate).[12] Estradiol and testosterone are attrac-
tive delivery vectors, as 60–75% of cancer tumors (breast, ovar-
ian, and prostate) overexpress the estradiol and testosterone
receptors. Herein we report the first complexes bearing both
NHC ligands and hormone derivatives. The antimicrobial activi-
ty of this new class of AuI complexes was investigated in vitro
versus Gram-positive (Staphylococcus aureus) and Gram-nega-
tive (Escherichia coli) bacteria and in vivo on Galleria mellonella
larvae.
The complex [Au(Me2Im)Cl] (1) (Me2Im=1,3-dimethylimida-
zol-2-ylidene) was prepared from the corresponding silver pre-
cursor as reported.[13] An analogous method was followed for
the synthesis of [Au(MeMeOEtIm)Cl] (2) (MeMeOEtIm=1-(2-
methoxyethyl)-3-methylimidazol-2-ylidene). In that case, the
imidazolium salt [HMeMeOEtIm]Cl was isolated from the reac-
tion of 1-methylimidazole with 1-chloro-2-methoxyethane.[14]
Hereafter, the resulting compound 2 was obtained as a white
powder. The 1H NMR spectrum (CDCl3) of 2 shows two dou-
blets at 7.09 and 6.89 ppm, corresponding to the H4 and H5
protons of the imidazole ring; the N-CH2 and CH2-O signals
appear as multiplets centered at 4.32 and 3.70 ppm, respec-
tively. The CH3-N and O-CH3 signals are observed as singlets at
3.83 and 3.33 ppm, respectively. Crystals of 2 (CCDC 5391621)
were grown by slow diffusion of diethyl ether into a saturated
dichloromethane solution. Salient geometrical features are as
expected for this kind of compounds.[15] A view of the molecu-
lar structure of 2 and further details are provided in the Sup-
porting Information.
Reactions of compounds 1 and 2 with the estrogens ethyny-
lestradiol (EE) and ethisterone (ES) in the presence of sodium
methoxide results in the corresponding alkynylgold(I) com-
plexes [Au(Me2Im)(EE
@)] (3), [Au(MeMeOEtIm)(EE@)] (4), [Au-
(Me2Im)(ES
@)] (5), and [Au(MeMeOEtIm)(ES@)] (6) (Scheme 1 and
Supporting Information).
NMR spectroscopy confirmed that the coupling between the
starting carbene complexes 1 and 2 and the estrogens EE and
ES was successful. The 1H NMR spectra of 3 and 4 are very sim-
[a] A. Vell8, Dr. P. J. Sanz Miguel
Departamento de Qu&mica Inorg#nica, Instituto de S&ntesis Qu&mica y Cat#-
lisis Homog8nea, ISQCH, Universidad de Zaragoza-CSIC, 50009 Zaragoza
(Spain)
E-mail : pablo.sanz@unizar.es
[b] A. Vell8, Dr. D. Montagner
Chemistry Department, Maynooth University, Maynooth (Ireland)
E-mail : diego.montagner@nuim.ie
[c] A. Vell8, R. Maguire, Prof. Dr. K. Kavanagh
Biology Department, Maynooth University, Maynooth (Ireland)
Supporting information and the ORCID identification number(s) for the
author(s) of this article can be found under https://doi.org/10.1002/
cmdc.201700257.
ChemMedChem 2017, 12, 841 – 844 T 2017 Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim841
CommunicationsDOI: 10.1002/cmdc.201700257
ilar. In the case of complex 3, there are five peaks between
7.12 and 6.56 ppm, which correspond to the imidazole H4 and
H5 protons and to the three aromatic protons of the phenyl
ring of the estradiol. On the other hand, 1H NMR spectra of 5
and 6 are similar to those of 3 and 4, with the only exception
that there is a single aromatic proton in the testosterone
moiety at 5.71 ppm for both 5 and 6. All four complexes (3–6)
show several multiplets in the region 2.50–0.90 ppm corre-
sponding to the CH and CH2 protons of the three rings of es-
tradiol or testosterone. Complete NMR characterization
(1H NMR, 13C NMR, HSQC, HMBC) for compounds 3, 4, 5, and 6
is provided in the Supporting Information.
Compound 4 could be isolated as a crystalline material by
slow diffusion of diethyl ether into a solution of 4 in wet di-
chloromethane at @20 8C. The structure of complex 4 was un-
equivocally determined by single-crystal X-ray diffraction
(CCDC 1539163), although the quality of the crystals was poor.
This was probably due to the rapid decomposition brought
about by the presence of nine water molecules and four crys-
tallographically different units of 4 in the asymmetric unit. De-
composition refers here to the loss of crystallinity, as com-
plexes 3–6 are stable in solution for several days. Figure 1
shows a view of one of the molecules of 4. In the case of com-
plex 4, the gold ions are coordinated to the NHC ligands and
to the alkynyl fragments. C@Au@C bond angles show minimal
distortions. Mutual positioning of the estradiol fragment and
the imidazole ring form almost right angles. The crystal pack-
ing shows the formation pairs of molecules of 4, which built
columns along the b axis separated by water molecules (Sup-
porting Information). Within these constructions, the estradiol
fragments wrap the Au–NHC skeleton, which shows Au–Au
separations of 3.531(2) a (Au1–Au2) and 3.309(3) a (Au3–Au4).
Aurophilic contacts between pairs of gold atoms should not
be discarded here,[15b] especially for the latter distance, which
is slightly shorter than two times the van der Waals radius of
gold (3.32 a).
To test the antimicrobial activity, the carbene AuI precursors
1 and 2, the four complexes bearing estrogens (3–6), and the
two pro-ligands ethynylestradiol (EE) and ethisterone (ES) were
screened in in vitro antibacterial tests against two bacterial
strains: S. aureus (Gram positive) and E. coli (Gram negative).
Activities as MIC50 values are listed in Table 1, and are similar to
those of previously reported AuI–NHC complexes.[16]
As expected, both compounds EE and ES are inactive, and
the presence of the metal center is of fundamental importance
for antimicrobial activity. The two carbene precursors 1 and 2
are the most active among the complexes tested in both
Gram-positive and Gram-negative bacteria, with very low MIC50
values (average MIC50 : 4.1 and 5.85 mm for 1 and 2, respective-
ly). The presence of the estrogens seems to slightly decrease
the in vitro antimicrobial activity with respect to the two pre-
cursors 1 and 2. Besides, complexes 3 and 4, bearing an estra-
diol moiety, were much more active than the corresponding
testosterone species 5 and 6 (average MIC50 : 8.2 and 39.4 mm
for 3 and 4, and 95.0 and 69.2 mm for 5 and 6, respectively).
This could be correlated with the higher solubility of estradiol
Scheme 1. Synthesis of complexes 3–6.
Figure 1. View of the complex [Au(MeMeOEtIm)(EE@)] (4).
Table 1. Antimicrobial activity of selected compounds.
Compd MIC50 [mm]
[a]









[a] Minimum compound concentration required to inhibit growth by
50% relative to positive control ; values are the mean:SD of triplicate ex-
periments.
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derivatives 3 and 4 in comparison with the testosterone deriv-
atives (5 and 6). All complexes are considerably more active
against the Gram-negative E. coli (average MIC50 : 16.2 mm) than
against the Gram-positive S. aureus (average MIC50 : 57.8 mm).
In vivo toxicity profiling was carried out using the G. mello-
nella insect model as described in the Supporting Information.
Due to the many similarities between the immune system of
insects and the innate immune system of mammals,[17,18] in-
sects have become popular choices for measuring the viru-
lence of microbial pathogens and for assessing the in vivo ac-
tivity of antimicrobial drugs.[19,20] Larvae of G. mellonella (the
greater wax moth) can be used to assess the pathogenicity of
microbial isolates[21] and the in vivo toxicity and therapeutic
potential of antimicrobial drugs;[5b,22] in fact, they can yield re-
sults that are comparable to those obtained using mammalian
models.[23,24] Insects have the benefit of being inexpensive to
purchase and house and can give results in 24–48 hours.
G. mellonella larvae were administered the test solutions by
direct injection into the haemocoel through the last pro-leg.
Survival was monitored after 15, 24, and 48 h at 37 8C, and
death was assessed by the lack of movement in response to
stimulus together with discoloration of the cuticle.
The toxicity of all of the test samples was assessed at three
different concentrations (150, 75, and 37.5 mm). We tested the
two precursors 1 and 2 together with the estradiol derivatives
3 and 4, which resulted in the most active species on the in vi-
tro studies. All the four tested complexes do not show any tox-
icity until 150 mm concentration after 24 h. Furthermore, the
antimicrobial activity of complexes 1–4 was studied in vivo in-
fecting the larvae with E. coli after treatment with nontoxic
concentration of the gold(I) complexes 1–4. As described in
the Supporting Information, the larvae were treated with the
highest nontoxic concentration of each complex (150 mm), in-
cubated for 2 h at 37 8C, and then inoculated with E. coli. The
larvae were incubated again at 37 8C, and the effect on viability
was monitored after 15, 24, and 48 h (Figure 2). The larvae ino-
culated with complexes 3 and 4 (those containing the estradiol
moiety) demonstrated increased survival with respect to the
control. In particular, complex 4 seems to be the most active,
with larval survival of >80%. Complexes 1 and 2 (the carbene
precursors) did not show any significant increase in larval sur-
vival with respect to the control, even if in vitro studies
showed the highest activity.
In conclusion, pioneering complexes that combine NHC li-
gands and hormone derivatives (ethynylestradiol and ethister-
one) showed interesting in vitro antibacterial properties. The
toxicity studies reveal that the presence of estradiol positively
affects the in vivo antibacterial activity of the gold(I) carbene
complexes. This finding may represent a significant new devel-
opment in the use of metal–estrogens as effective antimicrobi-
al agents.
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